Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacoinvasive Therapy With Prourokinase

This study has been completed.
Information provided by (Responsible Party):
Suzhou Landing Pharmaceuticals Identifier:
First received: July 13, 2012
Last updated: July 26, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):